0000950170-24-072066.txt : 20240611 0000950170-24-072066.hdr.sgml : 20240611 20240611172420 ACCESSION NUMBER: 0000950170-24-072066 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240608 FILED AS OF DATE: 20240611 DATE AS OF CHANGE: 20240611 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Henderson Jane CENTRAL INDEX KEY: 0001422304 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38944 FILM NUMBER: 241036808 MAIL ADDRESS: STREET 1: C/O ELEVEN BIOTHERAPEUTICS, INC. STREET 2: 215 FIRST STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Akero Therapeutics, Inc. CENTRAL INDEX KEY: 0001744659 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 601 GATEWAY BOULEVARD, SUITE 350 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650-487-6488 MAIL ADDRESS: STREET 1: 601 GATEWAY BOULEVARD, SUITE 350 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 4 1 ownership.xml 4 X0508 4 2024-06-08 0001744659 Akero Therapeutics, Inc. AKRO 0001422304 Henderson Jane 601 GATEWAY BOULEVARD SUITE 350 SOUTH SAN FRANCISCO CA 94080 true false false false false Stock Option (Right to Buy) 23.02 2024-06-08 4 A false 26000 0 A 2034-06-07 Common Stock 26000 26000 D This option shall vest in full on the earlier of (i) June 7, 2025, and (ii) the next annual meeting of the Company's stockholders, subject to the director's continued service on the Board. /s/ Jonathan Young, Attorney-in-Fact 2024-06-11